104 related articles for article (PubMed ID: 9877444)
1. A novel sensitive and selective bioassay for human type I interferons.
Files JG; Gray JL; Do LT; Foley WP; Gabe JD; Nestaas E; Pungor E
J Interferon Cytokine Res; 1998 Dec; 18(12):1019-24. PubMed ID: 9877444
[TBL] [Abstract][Full Text] [Related]
2. Regulation of IFN-alpha/beta, MxA, 2',5'-oligoadenylate synthetase, and HLA gene expression in influenza A-infected human lung epithelial cells.
Ronni T; Matikainen S; Sareneva T; Melén K; Pirhonen J; Keskinen P; Julkunen I
J Immunol; 1997 Mar; 158(5):2363-74. PubMed ID: 9036986
[TBL] [Abstract][Full Text] [Related]
3. A novel bioassay for the determination of neutralizing antibodies to IFN-beta1b.
Pungor E; Files JG; Gabe JD; Do LT; Foley WP; Gray JL; Nelson JW; Nestaas E; Taylor JL; Grossberg SE
J Interferon Cytokine Res; 1998 Dec; 18(12):1025-30. PubMed ID: 9877445
[TBL] [Abstract][Full Text] [Related]
4. Quantification of different human alpha interferon subtypes and pegylated interferon activities by measuring MxA promoter activation.
François C; Bernard I; Castelain S; Charleston B; Fray MD; Capiod JC; Duverlie G
Antimicrob Agents Chemother; 2005 Sep; 49(9):3770-5. PubMed ID: 16127052
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of a real time PCR-based bioassay for quantification of neutralizing antibodies against human interferon-beta.
Bertolotto A; Sala A; Caldano M; Capobianco M; Malucchi S; Marnetto F; Gilli F
J Immunol Methods; 2007 Apr; 321(1-2):19-31. PubMed ID: 17335844
[TBL] [Abstract][Full Text] [Related]
6. The proximal interferon-stimulated response elements are essential for interferon responsiveness: a promoter analysis of the antiviral MxA gene.
Ronni T; Matikainen S; Lehtonen A; Palvimo J; Dellis J; Van Eylen F; Goetschy JF; Horisberger M; Content J; Julkunen I
J Interferon Cytokine Res; 1998 Sep; 18(9):773-81. PubMed ID: 9781817
[TBL] [Abstract][Full Text] [Related]
7. Control of IFN-inducible MxA gene expression in human cells.
Ronni T; Melén K; Malygin A; Julkunen I
J Immunol; 1993 Mar; 150(5):1715-26. PubMed ID: 7679692
[TBL] [Abstract][Full Text] [Related]
8. Correlation of interferon-induced expression of MxA mRNA in peripheral blood mononuclear cells with the response of patients with chronic active hepatitis C to IFN-alpha therapy.
Antonelli G; Simeoni E; Turriziani O; Tesoro R; Redaelli A; Roffi L; Antonelli L; Pistello M; Dianzani F
J Interferon Cytokine Res; 1999 Mar; 19(3):243-51. PubMed ID: 10213463
[TBL] [Abstract][Full Text] [Related]
9. Increased levels of antiviral MxA protein in peripheral blood of patients with a chronic disease of unknown etiology.
Chieux V; Chehadeh W; Hautecoeur P; Harvey J; Wattré P; Hober D
J Med Virol; 2001 Oct; 65(2):301-8. PubMed ID: 11536237
[TBL] [Abstract][Full Text] [Related]
10. Measured neutralizing titers of IFN-beta neutralizing antibodies (NAbs) can depend on the preparations of IFN-beta used in the assay.
Files JG; Hargrove D; Delute L; Cantillon M
J Interferon Cytokine Res; 2007 Aug; 27(8):637-42. PubMed ID: 17784815
[TBL] [Abstract][Full Text] [Related]
11. A bioassay for serum interferon based on induction of 2'5'-oligoadenylate synthetase activity.
Uno K; Sato T; Takada Y; Fujioka K; Suginoshita Y; Kakimi K; Moriyasu F; Kishida T
J Interferon Cytokine Res; 1998 Dec; 18(12):1011-8. PubMed ID: 9877443
[TBL] [Abstract][Full Text] [Related]
12. IFN-alpha induces MxA gene expression in cultured human corneal fibroblasts.
Abrams ME; Balish MJ; Brandt CR
Exp Eye Res; 1995 Feb; 60(2):137-42. PubMed ID: 7540146
[TBL] [Abstract][Full Text] [Related]
13. Interferons, Mx genes, and resistance to influenza virus.
Horisberger MA
Am J Respir Crit Care Med; 1995 Oct; 152(4 Pt 2):S67-71. PubMed ID: 7551417
[TBL] [Abstract][Full Text] [Related]
14. A novel, quantitative bioassay for type I interferon using a recombinant indicator cell line.
Lleonart R; Näf D; Browning H; Weissmann C
Biotechnology (N Y); 1990 Dec; 8(12):1263-7. PubMed ID: 1366960
[TBL] [Abstract][Full Text] [Related]
15. Promoter structure of the MxA gene that confers resistance to influenza virus.
Nakade K; Handa H; Nagata K
FEBS Lett; 1997 Dec; 418(3):315-8. PubMed ID: 9428735
[TBL] [Abstract][Full Text] [Related]
16. Strong transient expression of the type I interferon-induced MxA protein in hepatitis A but not in acute hepatitis B and C.
Jakschies D; Zachoval R; Müller R; Manns M; Nolte KU; Hochkeppel HK; Horisberger MA; Deicher H; Von Wussow P
Hepatology; 1994 Apr; 19(4):857-65. PubMed ID: 8138257
[TBL] [Abstract][Full Text] [Related]
17. Activation of IFN-alpha, IFN-gamma, MxA, and IFN regulatory factor 1 genes in influenza A virus-infected human peripheral blood mononuclear cells.
Ronni T; Sareneva T; Pirhonen J; Julkunen I
J Immunol; 1995 Mar; 154(6):2764-74. PubMed ID: 7876547
[TBL] [Abstract][Full Text] [Related]
18. WISH cell line: from the antiviral system to a novel reporter gene assay to test the potency of human IFN-α and IFN-β.
Bürgi Mde L; Prieto C; Etcheverrigaray M; Kratje R; Oggero M; Bollati-Fogolín M
J Immunol Methods; 2012 Jul; 381(1-2):70-4. PubMed ID: 22549076
[TBL] [Abstract][Full Text] [Related]
19. A Novel Cell-based In vitro Assay for Antiviral Activity of Interferons α, β, and γ by qPCR of MxA Gene Expression.
Saber MA; Okasha H; Khorshed F; Samir S
Recent Pat Biotechnol; 2021; 15(1):67-75. PubMed ID: 33183215
[TBL] [Abstract][Full Text] [Related]
20. Correlation between the anti-virus-induced cytopathic effect activity of interferon-alpha subtypes and induction of MxA protein in vitro.
Schanen C; Chieux V; Lobert PE; Harvey J; Hober D
Microbiol Immunol; 2006; 50(1):19-24. PubMed ID: 16428869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
